NURS 5334 QUIZ 2 STUDY GUIDE EXAMS
SET TEST PAPER QUESTIONS AND
SOLUTIONS 2026-2027 VIEW AHEAD
EXAM.
⫸ Older adults. Answer: Thinner skin → higher risk of steroid-
induced atrophy.
⫸ Hormonal therapy (OCPs). Answer: May be used in women for
acne.
⫸ Isotretinoin, acitretin, and finasteride. Answer: Avoid in pregnancy
due to teratogenic effects.
⫸ Topical metronidazole and azelaic acid. Answer: Safe in
pregnancy.
⫸ Terbinafine. Answer: Avoid in breastfeeding as it accumulates in
milk.
⫸ Psoriasis treatment. Answer: Start with cost-effective topicals
(steroids, vitamin D analogues); escalate to systemic therapy if >5%
BSA.
,⫸ Acne first-line treatments. Answer: Benzoyl peroxide and
retinoids are inexpensive and effective.
⫸ Isotretinoin. Answer: Requires monitoring and registration.
⫸ Eczema treatment. Answer: Emollients and steroids are first-line;
calcineurin inhibitors for steroid-sparing use.
⫸ Topical steroids monitoring. Answer: Monitor for skin atrophy,
striae, hypopigmentation.
⫸ Isotretinoin monitoring. Answer: Monitor liver function, lipids,
pregnancy tests.
⫸ Antifungals monitoring. Answer: Monitor LFTs for terbinafine
and azoles.
⫸ Methotrexate monitoring (psoriasis). Answer: Monitor CBC,
LFTs, renal function.
⫸ Infants/Children drug precautions. Answer: Avoid systemic
steroids; cautious with high-potency topicals.
⫸ Pregnant women drug precautions. Answer: Avoid teratogenic
drugs (isotretinoin, acitretin, finasteride, methoxsalen).
,⫸ Older adults drug precautions. Answer: Higher risk of adverse
skin thinning with steroids.
⫸ Transgender patients. Answer: Consider hormonal therapies
(OCPs, spironolactone) with attention to interactions.
⫸ Sunscreen application. Answer: Apply 3 tbsp every 2 hrs, broad
spectrum ≥SPF 30.
⫸ Steroid use. Answer: Apply thin layer, lowest potency, avoid
face/perineum unless directed.
⫸ Acne medications. Answer: Retinoids may worsen acne before
improving; isotretinoin requires iPledge compliance.
⫸ Oral terbinafine for onychomycosis. Answer: Must be taken for
months.
⫸ Griseofulvin drug-food interaction. Answer: With fatty meals ↑
absorption.
⫸ Legal prescriptions. Answer: Follow state-specific requirements
for APRN prescriptive authority.
⫸ Generic names in prescriptions. Answer: Use when possible;
include strength, dosage, route, frequency, and duration.
, ⫸ Controlled/teratogenic medications. Answer: Ensure they follow
federal monitoring programs.
⫸ Epidermis. Answer: Protective layer, stratum corneum with
lipids/keratin.
⫸ Dermis. Answer: Connective tissue, sweat glands, sebaceous
glands, hair follicles, vessels.
⫸ Ointment. Answer: Oil-based, occlusive, best for dry, scaly
lesions.
⫸ Cream. Answer: Water-based, less greasy, for moist/weeping
lesions.
⫸ Lotion/Solution/Gel/Foam. Answer: Useful for hairy areas and
widespread application.
⫸ Retinoids. Answer: Comedolytic, anti-inflammatory agents used
in acne treatment.
⫸ Benzoyl peroxide. Answer: Antibacterial against P. acnes.
⫸ Topical antibiotics. Answer: Includes clindamycin, erythromycin,
dapsone.
SET TEST PAPER QUESTIONS AND
SOLUTIONS 2026-2027 VIEW AHEAD
EXAM.
⫸ Older adults. Answer: Thinner skin → higher risk of steroid-
induced atrophy.
⫸ Hormonal therapy (OCPs). Answer: May be used in women for
acne.
⫸ Isotretinoin, acitretin, and finasteride. Answer: Avoid in pregnancy
due to teratogenic effects.
⫸ Topical metronidazole and azelaic acid. Answer: Safe in
pregnancy.
⫸ Terbinafine. Answer: Avoid in breastfeeding as it accumulates in
milk.
⫸ Psoriasis treatment. Answer: Start with cost-effective topicals
(steroids, vitamin D analogues); escalate to systemic therapy if >5%
BSA.
,⫸ Acne first-line treatments. Answer: Benzoyl peroxide and
retinoids are inexpensive and effective.
⫸ Isotretinoin. Answer: Requires monitoring and registration.
⫸ Eczema treatment. Answer: Emollients and steroids are first-line;
calcineurin inhibitors for steroid-sparing use.
⫸ Topical steroids monitoring. Answer: Monitor for skin atrophy,
striae, hypopigmentation.
⫸ Isotretinoin monitoring. Answer: Monitor liver function, lipids,
pregnancy tests.
⫸ Antifungals monitoring. Answer: Monitor LFTs for terbinafine
and azoles.
⫸ Methotrexate monitoring (psoriasis). Answer: Monitor CBC,
LFTs, renal function.
⫸ Infants/Children drug precautions. Answer: Avoid systemic
steroids; cautious with high-potency topicals.
⫸ Pregnant women drug precautions. Answer: Avoid teratogenic
drugs (isotretinoin, acitretin, finasteride, methoxsalen).
,⫸ Older adults drug precautions. Answer: Higher risk of adverse
skin thinning with steroids.
⫸ Transgender patients. Answer: Consider hormonal therapies
(OCPs, spironolactone) with attention to interactions.
⫸ Sunscreen application. Answer: Apply 3 tbsp every 2 hrs, broad
spectrum ≥SPF 30.
⫸ Steroid use. Answer: Apply thin layer, lowest potency, avoid
face/perineum unless directed.
⫸ Acne medications. Answer: Retinoids may worsen acne before
improving; isotretinoin requires iPledge compliance.
⫸ Oral terbinafine for onychomycosis. Answer: Must be taken for
months.
⫸ Griseofulvin drug-food interaction. Answer: With fatty meals ↑
absorption.
⫸ Legal prescriptions. Answer: Follow state-specific requirements
for APRN prescriptive authority.
⫸ Generic names in prescriptions. Answer: Use when possible;
include strength, dosage, route, frequency, and duration.
, ⫸ Controlled/teratogenic medications. Answer: Ensure they follow
federal monitoring programs.
⫸ Epidermis. Answer: Protective layer, stratum corneum with
lipids/keratin.
⫸ Dermis. Answer: Connective tissue, sweat glands, sebaceous
glands, hair follicles, vessels.
⫸ Ointment. Answer: Oil-based, occlusive, best for dry, scaly
lesions.
⫸ Cream. Answer: Water-based, less greasy, for moist/weeping
lesions.
⫸ Lotion/Solution/Gel/Foam. Answer: Useful for hairy areas and
widespread application.
⫸ Retinoids. Answer: Comedolytic, anti-inflammatory agents used
in acne treatment.
⫸ Benzoyl peroxide. Answer: Antibacterial against P. acnes.
⫸ Topical antibiotics. Answer: Includes clindamycin, erythromycin,
dapsone.
